Advancing Science. Delivering Solutions.
Noramco is a leading specialty active pharmaceutical ingredient (API) development and manufacturing company that supports the advancement of opioid and non-opioid products in a range of therapeutic applications. Founded in 1979, the company is headquartered in Delaware and maintains operations around the world.
Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry:
– Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply
– High-purity controlled substances from narcotic raw materials
– Formulation-friendly particle size grades and extended technical packages
– Supporting world-class supply security of controlled substances, from schedule I to schedule III
The Leader in Addiction Treatment and Abuse Prevention (ATAP)
- More than a decade of large-scale manufacture in Nal-family compounds
- High-purity Naloxone, Naltrexone, Naltrexone HCI, Buprenorphine Base, and Buprenorphine HCI
- Long-term commitment to Addiction Treatment and Abuse Prevention products (ATAP)
- Specific particle sizes meet formulation requirements
Trusted Partner for
Comprehensive ADHD Technology
- cGMP manufacture of multimetric-ton supplies for world markets
- Custom particle sizes to meet formulation requirements
- Global regulatory footprint and experience
- High-quality Methylphenidate HCI, DexMethylphenidate,
and Lisdexamfetamine